NovaBay Pharmaceuticals Historical Earnings image   This NBY historical earnings page last updated 1/19/2023
NovaBay Pharmaceuticals Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/14/20220.00B
Q2 20228/11/20220.00B
Q1 20225/12/20220.00B
Q4 20213/29/20220.00B
Q3 202111/11/20210.00B
Q2 20218/12/20210.00B
Q1 20215/6/20210.00B
Q4 20203/25/20210.00B
Q3 202011/12/20200.00B
Q2 20208/6/20200.00B
Q1 20205/7/20200.00B
Q4 20193/26/20200.00B
Q3 201911/7/20190.00B
Q2 20198/7/20190.00B
Q1 20195/9/20190.00B
Q4 20183/28/20193.62M
Q3 201811/14/20183.14M
Q2 20188/7/20182.79M
Q1 20185/10/20182.95M
Q4 20173/20/20186.32M
Q3 201711/14/20174.09M
Q2 20178/10/20174.12M
Q1 20175/11/20173.70M
Q4 20163/23/20174.08M
Q3 201611/10/20163.44M
Q2 20168/11/20162.66M
Q1 20165/12/20161.72M
Q4 20153/3/20161.64M
Q3 201511/19/20151.20M
Q2 20158/13/20151.01M
Q1 20155/14/2015492000
FY 20143/26/2015385000
Q3 201411/12/201490000
Q2 20147/31/201421000
Q1 20145/1/2014188000
FY 20133/7/2014300000
Q3 201311/14/2013-1000
Q2 20138/1/201317000
Q1 20135/2/201363000
Q4 20123/14/20131.10M
Q3 201211/1/20123.64M
Q2 20128/9/20120.00B
NovaBay Pharmaceuticals Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202211/14/2022-3.500
Q2 20228/11/2022-1.400
Q1 20225/12/2022-1.750
Q4 20213/29/2022-4.200
Q3 202111/11/2021-1.750
Q2 20218/12/2021-1.400
Q1 20215/6/2021-1.400
Q4 20203/25/2021-1.400
Q3 202011/12/2020-2.800
Q2 20208/6/2020-5.250
Q1 20205/7/2020-2.100
Q4 20193/26/2020-4.550
Q3 201911/7/2019-0.700
Q2 20198/7/2019-4.900
Q1 20195/9/2019-9.800
Q4 20183/28/2019-2.450
Q3 201811/14/2018-3.850
Q2 20188/7/2018-4.200
Q1 20185/10/2018-4.900
Q4 20173/20/20180.700
Q3 201711/14/2017-5.600
Q2 20178/10/2017-3.850
Q1 20175/11/2017-9.100
Q4 20163/23/2017-4.550
Q3 201611/10/2016-11.900
Q2 20168/11/2016-12.600
Q1 20165/12/2016-36.750
Q4 20153/3/2016-44.100
Q3 201511/19/2015-61.250
Q2 20158/13/2015-61.250
Q1 20155/14/2015-78.750
FY 20143/26/2015-78.750
Q3 201411/12/2014-70.000
Q2 20147/31/2014-52.500
Q1 20145/1/2014-70.000
FY 20133/7/2014-367.500
Q3 201311/14/2013-87.500
Q2 20138/1/2013-96.250
Q1 20135/2/2013-96.250
Q4 20123/14/2013-70.000
Q3 201211/1/20120
Q2 20128/9/2012-0.08
What was the record high NBY historical earnings result?
In terms of earnings or revenue, what is the best NBY historical earnings result that NovaBay Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest NBY historical earnings result was set in Q4 2017, when NovaBay Pharmaceuticals posted results of 0.700/share. The most successful revenue quarter within our data set was Q4 2017 when NovaBay Pharmaceuticals reported revenue of 6.32M.

What was the lowest NovaBay Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest NBY has reported, and when?

✔️Accepted answer: Within our data set, the lowest NBY historical earnings result was set in FY 2013, when NovaBay Pharmaceuticals posted results of -367.500/share. The smallest revenue quarter within our data set was Q3 2013 when NovaBay Pharmaceuticals reported revenue of -1000.

On this page we presented the NBY historical earnings date information for NovaBay Pharmaceuticals. Reviewing that NovaBay Pharmaceuticals Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2017, when NBY posted gaap of 0.700/share. Meanwhile the lowest NBY historical earnings result was in FY 2013, when NBY posted gaap of -367.500/share. Moving to NovaBay Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2017 when NBY reported 6.32M in revenue, while the smallest revenue quarter was Q3 2013 when NBY reported -1000 in revenue.

For self directed investors doing their due diligence on NBY or any other given stock, their research can benefit from looking into all of the NovaBay Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into NovaBay Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for NBY. Thanks for visiting, and the next time you need to research NBY historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Institutional Holders of AVPT, Institutional Holders of THCB, ML Average Annual Return.

 

NovaBay Pharmaceuticals Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.